A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer

Clinical trial NCT03167112 · UNKNOWN

Trial details

NCT number: NCT03167112
Sponsor: Petr Kavan
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2017-07-03
Primary completion: 2018-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.